Many cancer specialists describe immunotherapy as the most promising direction in modern oncology. Research is moving quickly. New drugs are approved often. Some cancers that once had limited options now respond well to immune based treatments. Chemotherapy attacks cancer cells directly and hits healthy cells along the way.
Immunotherapy takes a different approach. It trains the immune system so it can target cancer cells. Some treatments boost immune activity. Others help the immune system see signals that cancer cells use to hide. When immunotherapy works well the response can last because the immune system remembers what it has learned. This can lead to long periods of stability for some patients.
Chemo side effects follow a pattern, are usually predictable, but are more common. Immunotherapy side effects are less common, but when they appear they come from an overactive immune system and can be more serious.
In practical terms one treatment is not automatically better than the other. Chemotherapy remains important and also continues to improve. The choice depends on the type of cancer, how fast it grows, how the body responds and what the specialist aims to achieve. Some cancers respond well to chemo. Others respond better to immunotherapy. Many treatment plans combine both at different stages.
Which one to choose? The next step is to speak with a qualified clinic or specialist.